Related Experiment Video
Updated: Aug 4, 2025

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
CDK5-PRMT1-WDR24 signaling cascade promotes mTORC1 signaling and tumor growth
Shasha Yin1, Liu Liu1, Lauren E Ball2
1Department of Biochemistry and Molecular Biology, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC 29425, USA.
Abstract:
The mammalian target of rapamycin complex1 (mTORC1) is a central regulator of metabolism and cell growth by sensing diverse environmental signals, including amino acids. The GATOR2 complex is a key component linking amino acid signals to mTORC1. Here, we identify protein arginine methyltransferase 1 (PRMT1) as a critical regulator of GATOR2. In response to amino acids, cyclin-dependent kinase 5 (CDK5) phosphorylates PRMT1 at S307 to promote PRMT1 translocation from nucleus to cytoplasm and lysosome, which in turn methylates WDR24, an essential component of GATOR2, to activate the mTORC1 pathway. Disruption of the CDK5-PRMT1-WDR24 axis suppresses hepatocellular carcinoma (HCC) cell proliferation and xenograft tumor growth. High PRMT1 protein expression is associated with elevated mTORC1 signaling in patients with HCC. Thus, our study dissects a phosphorylation- and arginine methylation-dependent regulatory mechanism of mTORC1 activation and tumor growth and provides a molecular basis to target this pathway for cancer therapy.
Insights
Protein arginine methyltransferase 1 (PRMT1) regulates the GATOR2 complex and mTORC1 signaling. Targeting the CDK5-PRMT1-WDR24 pathway inhibits hepatocellular carcinoma cell growth and tumor progression.
Area of Science:
- Cellular Biology
- Molecular Oncology
- Signal Transduction
Background:
- Mammalian target of rapamycin complex 1 (mTORC1) controls cell growth and metabolism.
- The GATOR2 complex links amino acid availability to mTORC1.
- Dysregulated mTORC1 signaling contributes to cancer development.
Purpose of the Study:
- To identify novel regulators of the GATOR2 complex and mTORC1 signaling.
- To elucidate the molecular mechanism linking amino acid sensing to mTORC1 activation.
- To investigate the therapeutic potential of targeting this pathway in hepatocellular carcinoma (HCC).
Main Methods:
- Protein interaction studies
- Phosphorylation and methylation assays
- Cell proliferation assays
- Xenograft tumor models
- Analysis of patient HCC samples
Main Results:
- Protein arginine methyltransferase 1 (PRMT1) was identified as a key regulator of GATOR2.
- Cyclin-dependent kinase 5 (CDK5) phosphorylates PRMT1, promoting its translocation and subsequent methylation of WDR24.
- This CDK5-PRMT1-WDR24 axis activates mTORC1 signaling.
- Disrupting this axis suppressed HCC cell proliferation and tumor growth.
- High PRMT1 expression correlated with elevated mTORC1 signaling in HCC patients.
Conclusions:
- A novel regulatory mechanism involving phosphorylation and arginine methylation controls mTORC1 activation.
- The CDK5-PRMT1-WDR24 pathway is crucial for HCC cell growth.
- Targeting this pathway offers a potential therapeutic strategy for hepatocellular carcinoma.
More Related Videos
11:13Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
MAPK Signaling Cascades
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Abnormal Proliferation